Clinical Trial Update: ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tradipitant for severe or critical COVID-19 infection is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Tradipitant (tradipitant)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Coronavirus Infection | Phase 3 | Status: ENROLLING_BY_INVITATION